Premium
Negatively Charged Gold Nanoparticles Inhibit Alzheimer's Amyloid‐β Fibrillization, Induce Fibril Dissociation, and Mitigate Neurotoxicity
Author(s) -
Liao YiHung,
Chang YuJen,
Yoshiike Yuji,
Chang YunChorng,
Chen YunRu
Publication year - 2012
Publication title -
small
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.785
H-Index - 236
eISSN - 1613-6829
pISSN - 1613-6810
DOI - 10.1002/smll.201201068
Subject(s) - fibril , colloidal gold , neurotoxicity , chemistry , biophysics , amyloid fibril , amyloid (mycology) , nanoparticle , amyloid β , nanotechnology , biochemistry , toxicity , materials science , biology , organic chemistry , disease , medicine , inorganic chemistry , pathology
Amyloids are pathogenic hallmarks in many neurodegenerative diseases such as amyloid‐ β (A β ) fibrils in Alzheimer's disease (AD). Here, the effect of gold nanoparticles (AuNPs) on amyloids is examined using A β as a model system. It is found that bare AuNPs inhibited A β fibrillization to form fragmented fibrils and spherical oligomers. Adding bare AuNPs to preformed A β fibrils results in ragged species where AuNPs bind preferentially to fibrils. Similar results are demonstrated with carboxyl‐ but not amine‐conjugated AuNPs. Co‐incubation of negatively charged AuNPs with A β relieved A β toxicity to neuroblastoma. Overall, it is demonstrated that AuNPs possessing negative surface potential serve as nano‐chaperones to inhibit and redirect A β fibrillization, which could contribute to applications for AD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom